Skip to content

Author

Maria Fernanda Imperio Pereira

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Human epidermal growth factor receptor 2-low is not a distinct subgroup in breast cancer patients undergoing neoadjuvant chemotherapy

Introduction: Breast cancer is a heterogeneous disease, and patients with low expression of human epidermal growth factor receptor 2 (HER2) benefit from antibody-drug conjugate therapies. Objective: To investigate the association between HER2-low status and survival and pathologic complete response (pCR) in breast can...

D. G. Tiezzi, Laura de Martin Coletti, Gustavo Motta Cabello dos Santos et al. · 0 citations
Review Open access Sep 2026

Mechanisms of antitumor immune response suppression mediated by myeloid-derived suppressor cells in colorectal cancer

Findings reinforce the central role of MDSCs in colorectal cancer progression and highlight their potential as therapeutic targets, but the high heterogeneity of these cells and the lack of standardized methods for their identification remain challenges for their clinical application.

Maria Fernanda Imperio Pereira, Emilly Paschoal de Oliveira, Valéria de Lima Kaminski · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.